Coluban, Merlito .

HRN: 00-51-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2023
CEFTRIAXONE 1G (VIAL)
11/25/2023
12/02/2023
IVT
2g
Q24
Septic Shock
Waiting Final Action 
11/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/25/2023
12/09/2023
IV
500mg
Q8hr
T/C Liver Abscess
Waiting Final Action 
11/25/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/25/2023
12/09/2023
IV
4.5g
Q6hr
T/C Liver Abscess
Waiting Final Action 
12/04/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/04/2023
12/10/2023
IV
500mg
OD
Liver Abscess
Waiting Final Action 
12/05/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/05/2023
12/11/2023
IVT
500mg
Od
Liver Abscess
Waiting Final Action 
12/05/2023
METRONIDAZOLE 500MG (TAB)
12/05/2023
12/11/2023
PO
750mg (1 1/2 Tab)
Tid
Liver Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: